| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |